BC Innovations | Sep 8, 2011
Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Chronic obstructive pulmonary disease (COPD) Adrenergic receptor b2 (ADRB2); muscarinic acetylcholine receptor M3 (CHRM3; HM3) In vitro and ex vivo studies suggest a conjugate...
Items per page:
1 - 1 of 1